Solutions for Drama-Free mAb Development
Last updated: July 2023
Overview
Therapeutic monoclonal antibodies (mAbs) are produced via a laborious multi-step process involving cell line development (CLD), antibody isolation and purification, and extensive testing.
Although this approach is effective, as evidenced by the number of mAb therapeutics that have been commercialized, it has a high risk of failure and is often unsuitable for poorly immunogenic targets. As a result, researchers are choosing to incorporate state-of-the-art technologies for rapid identification, characterization and purification of candidate molecules into mAb development workflows, to increase their chances of discovering the next novel drug.
Read this article to learn how Sartoclear Dynamics® Lab kits can revolutionize your cell culture clarification and filtration process.
- Document type: Article
- Page count: 4
- Read time: 8 minutes
Key Takeaways
- Importance of mAbs in biotherapeutic development
- Key steps in the mAb development process
- Solutions to streamline mAb development, such as Sartoclear Dynamics® Lab kits for one-step clarification and filtration
This Resource is Designed for:
- Researchers and Scientists Involved in the Development of Biotherapeutics, Particularly Those Working With Monoclonal Antibodies (mAbs)
- Biopharmaceutical Companies Focused on Mab Development
- Lab Professionals
- Lab Technicians
Applications Supported:
- Therapeutic monoclonal antibodies (mAbs)
- Cell line development (CLD) and molecule development
Resource Preview
